
|Articles|November 30, 2017
Bioclinica Launches Clinical Adjudication for Enhanced Safety and Efficacy in Clinical Trials
Advertisement
Bioclinica® announced the launch of Bioclinica Clinical Adjudication, an offering in which medical specialists and researchers, backed by technology, lead independent Clinical Event Committee review. The new service enables the independent adjudication of clinical events in conformance with regulatory requirements governing clinical trials within all therapeutic areas. Bioclinica will bring in professionals who specilize in each particular endpoint area and this adjudication will ultimately help manage the complete process.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Career They Didn't Train For: Rethinking Early-Career Burnout in Clinical Research
2
Breaking the Efficacy Ceiling in IBD and Beyond
3
ACT Brief: Substance Versus Branding in Biotech Support, Site-Level Execution Gaps and Point-of-Care Data, and KCNT1-Targeted Pediatric Epilepsy Program
4
Why Clinical Trial Modernization Fails Without Point-of-Care Data: Q&A with Richard Graham, PhD, TruTechnologies
5



